Je. Dohar et al., THERAPEUTIC IMPLICATIONS IN THE TREATMENT OF AURAL PSEUDOMONAS INFECTIONS BASED ON IN-VITRO SUSCEPTIBILITY PATTERNS, Archives of otolaryngology, head & neck surgery, 121(9), 1995, pp. 1022-1025
Objective: To examine the in vitro susceptibility patterns of aural is
olates of Pseudomonas aeruginosa and to identify changes over a 4-year
period. Design: Retrospective case series. Setting: The outpatient de
partment at Children's Hospital of Pittsburgh (Pa), a tertiary referra
l center. Patients: Ambulatory children younger than 18 years from who
se ears P aeruginosa was isolated. Outcome Measures: The in vitro susc
eptibility of aural isolates of P aeruginosa to ampicillin, cefotaxime
, chloramphenicol, sulfisoxazole, ticarcillin, mezlocillin, gentamicin
, tobramycin, cefazolin, tetracycline, piperacillin, nitrofurantoin, c
ephalexin hydrochloride, ceftriaxone, cefuroxime axetil, and sulfameth
oxazole-trimethoprim. Results and Conclusions: No changes were found i
n the trends of the susceptibility patterns over the 4-year study peri
od, with the exception of the semisynthetic penicillins, ticarcillin a
nd mezlocillin. These two agents were found to be relatively ineffecti
ve against the strains of P aeruginosa isolated in 1989 (59% and 18% s
usceptibility, respectively). This finding is in contrast to their eff
ectiveness over the remainder of the study period (96% and 90% suscept
ibility, respectively), which was excellent. These observations likely
reflect a change in the breakpoints for the minimal inhibitory concen
trations between these periods. The intravenous agent with the best su
sceptibility profile was piperacillin (96%). Of the aminoglycosides te
sted, 94% of the isolates were sensitive to tobramycin, as opposed to
only 79% for gentamicin. This finding may have significance when one i
s empirically selecting ototopical therapy, since both tobramycin and
gentamicin are available as topical preparations. Of the oral agents,
the combination of sulfamethoxazole-trimethoprim was most effective (4
6%).